Education
About Us
Working with TipRanks
Follow Us
PT Kalbe Farma (PTKFY)
:PTKFY
RESEARCH TOOLSreports
Total Valuation
PT Kalbe Farma Tbk has a market cap or net worth of $3.94B. The enterprise value is $4.18B.
Market Cap$3.94B
Enterprise Value$4.18B
Share Statistics
PT Kalbe Farma Tbk has 234,066,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding234,066,960
Owned by Insiders―
Owned by Institutions0.03%
Financial Efficiency
PT Kalbe Farma Tbk’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 12.23%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)12.23%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee2.54B
Profits Per Employee0.00
Employee Count12,841
Asset Turnover1.11
Inventory Turnover3.03
Valuation Ratios
The current PE Ratio of PT Kalbe Farma Tbk is 18.3. PT Kalbe Farma Tbk’s PEG ratio is 0.00003.
PE Ratio18.3
PS Ratio0.01
PB Ratio0.02
Price to Fair Value0.02
Price to FCF0.11
Price to Operating Cash Flow17.30
PEG Ratio0.00003
Income Statement
In the last 12 months, PT Kalbe Farma Tbk had revenue of 32.63T and earned 3.24T in profits. Earnings per share was 2.81M.
Revenue32.63T
Gross Profit12.96T
Operating Income4.07T
Pretax Income4.22T
Net Income3.24T
EBITDA4.61T
Earnings Per Share (EPS)2.81M
Cash Flow
In the last 12 months, operating cash flow was 3.71T and capital expenditures -845.68B, giving a free cash flow of 2.87T billion.
Operating Cash Flow3.71T
Free Cash Flow2.87T
Free Cash Flow per Share12.26K
Dividends & Yields
PT Kalbe Farma Tbk pays an annual dividend of $0.283, resulting in a dividend yield of 1.83%
Dividend Per Share$0.283
Dividend Yield1.83%
Payout Ratio30.70%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.35
52-Week Price Change-20.27%
50-Day Moving Average18.44
200-Day Moving Average16.67
Relative Strength Index (RSI)35.57
Average Volume (3m)0.00
Important Dates
PT Kalbe Farma Tbk upcoming earnings date is Oct 29, 2025, TBA (Confirmed).
Last Earnings DateJul 31, 2025
Next Earnings DateOct 29, 2025
Ex-Dividend DateJun 06, 2025
Financial Position
PT Kalbe Farma Tbk as a current ratio of 4.11, with Debt / Equity ratio of 3.48%
Current Ratio4.11
Quick Ratio2.55
Debt to Market Cap1.34
Net Debt to EBITDA-0.90
Interest Coverage Ratio72.22
Taxes
In the past 12 months, PT Kalbe Farma Tbk has paid 972.30B in taxes.
Income Tax972.30B
Effective Tax Rate0.23
Enterprise Valuation
PT Kalbe Farma Tbk EV to EBITDA ratio is 15.79, with an EV/FCF ratio of 20.61.
EV to Sales2.23
EV to EBITDA15.79
EV to Free Cash Flow20.61
EV to Operating Cash Flow15.23
Balance Sheet
PT Kalbe Farma Tbk has $3.95T in cash and marketable securities with $779.98B in debt, giving a net cash position of -$3.17T billion.
Cash & Marketable Securities$3.95T
Total Debt$779.98B
Net Cash-$3.17T
Net Cash Per Share-$13.55K
Tangible Book Value Per Share$19.28M
Margins
Gross margin is 40.18%, with operating margin of 12.47%, and net profit margin of 9.93%.
Gross Margin40.18%
Operating Margin12.47%
Pretax Margin12.93%
Net Profit Margin9.93%
EBITDA Margin14.14%
EBIT Margin13.10%
Analyst Forecast
The average price target for PT Kalbe Farma Tbk is $18.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$18.00
Price Target Upside6.89% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast2.45%
EPS Growth Forecast9.73%